Dr Mohamed Saad
Grant-Funded Researcher (C)
SAIGENCI
College of Health
Eligible to supervise Masters and PhD - email supervisor to discuss availability.
Dr Mohamed Saad is a Research Scientist at the South Australian immunoGENomics Cancer Institute (SAiGENCI), University of Adelaide, Adelaide, Australia. He completed his PhD studies in 2019 at Monash University, Australia. He has authored 37 publications and been awarded numerous highly competitive scholarships, fellowships and awards, including Monash International Postgraduate Research Scholarship, Monash Publication Award, Hudson Postgraduate Travel Fellowship Award, Best Poster Prize at the Lorne Cancer conference, Milstein Travel Award from the International Cytokine and Interferon Society, and Cancer Council Victoria (CCV) Postdoctoral Research Fellowship. In 2024, he was also awarded a Cure Cancer Early Career Research grant and a Tour de Cure grant. He was selected as 1 of 6 Hudson Institute Emerging Leaders in 2021. Dr Saad has presented his work at 18 national and international conferences and symposia, and has been invited to present his work at the University of Kiel, Germany (2019) and Technical University of Munich, Germany (2024). He is an active reviewer for many scientific journals including Oncogene, Molecular Therapy - Nucleic Acids, Molecular Cancer Research, Clinical & Translational Immunology, Cancers, Cytokine, Biomolecules and Cancer Medicine. In 2023, he was invited to edit a book entitled “Patient-derived Xenografts: A Valuable Platform for Translational Cancer Research and Drug Development” to be published (by mid-2024) in the highly regarded laboratory protocol series Methods in Molecular Biology, published by Springer Nature. He also joined the editorial board of Frontiers in Oncology as a Review Editor in 2022. His research interests include elucidating the roles of the ADAM17 protease, rhomboid pseudoproteases and IL-6 cytokine signaling in dysregulated cell proliferation, inflammation and cell death, with a particular focus on lung cancer.
| Date | Position | Institution name |
|---|---|---|
| 2019 - 2023 | Postdoctoral Scientist | Hudson Institute of Medical Research |
| Date | Institution name | Country | Title |
|---|---|---|---|
| 2015 - 2019 | Monash University | Australia | PhD |
| 2011 - 2014 | Alexandria University | Egypt | M.Sc |
| 2005 - 2010 | Alexandria University | Egypt | B.Sc |
| Year | Citation |
|---|---|
| 2026 | Chey, Y. C. J., Kashgari, B., McLeod, L., Radford, G. A., Gearing, L. J., Dawson, R. E., . . . Jenkins, B. J. (2026). Cancer cell-intrinsic inflammasome protein ASC links innate immunity with mitochondrial metabolism in driving pancreatic cancer. Nature Communications, 17(1), 2477-1-2477-21. Scopus1 WoS1 |
| 2026 | Khattab, H., Solujic, J., & Saad, M. I. (2026). ADAM proteases in cytokine biology: Modulators of immune signaling, inflammation and cancer. Biochimica et Biophysica Acta - Molecular Cell Research, 1873(4), 120137-1-120137-22. Scopus1 WoS2 |
| 2026 | Chan, S., Hon, K., Dawson, R. E., Weng, T., Solujic, J., Chey, Y. C. J., . . . Saad, M. I. (2026). The metalloproteinase ADAM17 promotes acute lung inflammatory responses during pancreatitis. British Journal of Pharmacology, 183(15), 4126-4144. WoS1 |
| 2024 | Saad, M. I., & Jenkins, B. J. (2024). The Protease ADAM17 at the Crossroads of Disease: Revisiting its Significance in Inflammation, Cancer, and Beyond. The FEBS journal, 291(1), 10-24. Scopus45 WoS49 Europe PMC44 |
| 2024 | Alanazi, M., Weng, T., McLeod, L., Gearing, L. J., Smith, J. A., Kumar, B., . . . Jenkins, B. J. (2024). Cytosolic DNA sensor AIM2 promotes KRAS-driven lung cancer independent of inflammasomes. Cancer Science, 115(6), 1834-1850. Scopus10 WoS11 Europe PMC10 |
| 2024 | Saad, M. I. (2024). Preface. Methods in Molecular Biology, 2806, v. |
| 2022 | Dawson, R. E., Deswaerte, V., West, A. C., Tang, K., West, A. J., Balic, J. J., . . . Jenkins, B. J. (2022). STAT3-mediated upregulation of the AIM2 DNA sensor links innate immunity with cell migration to promote epithelial tumourigenesis. Gut, 71(8), 1515-1531. Scopus37 WoS36 Europe PMC32 |
| 2022 | Alhayyani, S., McLeod, L., West, A. C., Balic, J. J., Hodges, C., Yu, L., . . . Jenkins, B. J. (2022). Oncogenic dependency on STAT3 serine phosphorylation in KRAS mutant lung cancer. Oncogene, 41(6), 809-823. Scopus11 WoS12 Europe PMC11 |
| 2022 | Ruwanpura, S. M., McLeod, L., Dousha, L. F., Seow, H. J., West, A. C., West, A. J., . . . Jenkins, B. J. (2022). Cross-talk between IL-6 trans-signaling and AIM2 inflammasome/IL-1β axes bridge innate immunity and epithelial apoptosis to promote emphysema. Proceedings of the National Academy of Sciences, 119(36), 1-12. Scopus27 WoS22 Europe PMC23 |
| 2022 | Saad, M. I., Weng, T., Lundy, J., Gearing, L. J., West, A. C., Harpur, C. M., . . . Jenkins, B. J. (2022). Blockade of the protease ADAM17 ameliorates experimental pancreatitis. Proceedings of the National Academy of Sciences of USA, 119(42), e2213744119-1-e2213744119-12. Scopus30 WoS26 Europe PMC25 |
| 2021 | Saad, M. I., McLeod, L., Hodges, C., Vlahos, R., Rose-John, S., Ruwanpura, S., & Jenkins, B. J. (2021). ADAM17 Deficiency Protects against Pulmonary Emphysema. American Journal of Respiratory Cell and Molecular Biology, 64(2), 183-195. Scopus27 WoS26 Europe PMC24 |
| 2021 | Dawson, R. E., Jenkins, B. J., & Saad, M. I. (2021). IL-6 family cytokines in respiratory health and disease. Cytokine, 143, 1-10. Scopus56 WoS51 Europe PMC43 |
| 2021 | Vannitamby, A., Saad, M. I., Aloe, C., Wang, H., Kumar, B., Vlahos, R., . . . Bozinovski, S. (2021). Aspirin-Triggered Resolvin D1 Reduces Proliferation and the Neutrophil to Lymphocyte Ratio in a Mutant KRAS-Driven Lung Adenocarcinoma Model. Cancers, 13(13), 1-16. Scopus19 WoS19 Europe PMC15 |
| 2020 | Saad, M. I., McLeod, L., Yu, L., Ebi, H., Ruwanpura, S., Sagi, I., . . . Jenkins, B. J. (2020). The ADAM17 protease promotes tobacco smoke carcinogen-induced lung tumorigenesis. Carcinogenesis, 41(4), 527-538. Scopus29 WoS29 Europe PMC28 |
| 2020 | Balic, J. J., Saad, M. I., Dawson, R., West, A. J., McLeod, L., West, A. C., . . . Jenkins, B. J. (2020). Constitutive STAT3 Serine Phosphorylation Promotes Helicobacter-Mediated Gastric Disease. The American Journal of Pathology, 190(6), 1256-1270. Scopus27 WoS22 Europe PMC21 |
| 2020 | Zhu, D., Kusuma, G. D., Schwab, R., Chan, S. T., Tan, J., Saad, M. I., . . . Lim, R. (2020). Prematurity negatively affects regenerative properties of human amniotic epithelial cells in the context of lung repair. Clinical Science, 134(20), 2665-2679. Scopus11 WoS9 Europe PMC8 |
| 2019 | Saad, M. I., Alhayyani, S., McLeod, L., Yu, L., Alanazi, M., Deswaerte, V., . . . Jenkins, B. J. (2019). ADAM17 selectively activates the IL-6 trans-signaling/ERK MAPK axis in KRAS-addicted lung cancer.. EMBO molecular medicine, 11(4), 1-19. Scopus83 WoS77 Europe PMC78 |
| 2019 | Saad., Rose-John., & Jenkins. (2019). ADAM17: An Emerging Therapeutic Target for Lung Cancer. Cancers, 11(9), 1-28. Scopus77 WoS66 Europe PMC60 |
| 2019 | Balic, J. J., Garama, D. J., Saad, M. I., Yu, L., West, A. C., West, A. J., . . . Jenkins, B. J. (2019). Serine-Phosphorylated STAT3 Promotes Tumorigenesis via Modulation of RNA Polymerase Transcriptional Activity. Cancer Research, 79(20), 5272-5287. Scopus31 WoS31 Europe PMC30 |
| 2018 | Tan, J. L., Lau, S. N., Leaw, B., Nguyen, H. P. T., Salamonsen, L. A., Saad, M. I., . . . Lim, R. (2018). Amnion Epithelial Cell-Derived Exosomes Restrict Lung Injury and Enhance Endogenous Lung Repair. Stem Cells Translational Medicine, 7(2), 180-196. Scopus193 WoS175 Europe PMC153 |
| 2017 | Alhomrani, M., Correia, J., Zavou, M., Leaw, B., Kuk, N., Xu, R., . . . Sievert, W. (2017). The human amnion epithelial cell secretome decreases hepatic fibrosis in mice with chronic liver fibrosis. Frontiers in Pharmacology, 8(OCT), 13 pages. Scopus80 WoS77 Europe PMC70 |
| 2017 | Leaw, B., Zhu, D., Tan, J., Muljadi, R., Saad, M. I., Mockler, J. C., . . . Tolcos, M. (2017). Human amnion epithelial cells rescue cell death via immunomodulation of microglia in a mouse model of perinatal brain injury. Stem Cell Research Therapy, 8(1), 46. Scopus41 WoS36 Europe PMC33 |
| 2017 | Moussa, Y. Y., Tawfik, S. H., Haiba, M. M., Saad, M. I., Hanafi, M. Y., Abdelkhalek, T. M., . . . Kamel, M. A. (2017). Disturbed nitric oxide and homocysteine production are involved in the increased risk of cardiovascular diseases in the F1 offspring of maternal obesity and malnutrition. Journal of Endocrinological Investigation, 40(6), 611-620. Scopus4 WoS3 Europe PMC1 |
| 2017 | Tawfik, S. H., Haiba, M. M., Saad, M. I., Abdelkhalek, T. M., Hanafi, M. Y., & Kamel, M. A. (2017). Intrauterine diabetic milieu instigates dysregulated adipocytokines production in F1 offspring. JOURNAL OF ANIMAL SCIENCE AND TECHNOLOGY, 59(1), 11 pages. WoS2 Europe PMC1 |
| 2016 | Hanafi, M. Y., Saad, M. I., Abdelkhalek, T. M., Saleh, M. M., & Kamel, M. A. (2016). In Utero Nutritional Manipulation Provokes Dysregulated Adipocytokines Production in F1 Offspring in Rats. Scientifica, 2016, 9 pages. Scopus3 WoS3 Europe PMC2 |
| 2016 | Saad, M. I., Abdelkhalek, T. M., Haiba, M. M., Saleh, M. M., Hanafi, M. Y., Tawfik, S. H., & Kamel, M. A. (2016). Maternal obesity and malnourishment exacerbate perinatal oxidative stress resulting in diabetogenic programming in F1 offspring. Journal of Endocrinological Investigation, 39(6), 643-655. Scopus18 WoS15 Europe PMC13 |
| 2016 | Saad, M. I., Abdelkhalek, T. M., Saleh, M. M., Haiba, M. M., Tawfik, S. H., & Kamel, M. A. (2016). Maternal diabetes impairs oxidative and inflammatory response in murine placenta. Springerplus, 5(1), 9 pages. Scopus11 WoS12 Europe PMC8 |
| 2016 | Hanafi, M. Y., Abdelkhalek, T. M., Saad, M. I., Saleh, M. M., Haiba, M. M., & Kamel, M. A. (2016). Diabetes-induced perturbations are subject to intergenerational transmission through maternal line. Journal of Physiology and Biochemistry, 72(2), 315-326. Scopus13 WoS12 Europe PMC8 |
| 2016 | Hanafi, M. Y., Saleh, M. M., Saad, M. I., Abdelkhalek, T. M., & Kamel, M. A. (2016). Transgenerational effects of obesity and malnourishment on diabetes risk in F2 generation. Molecular and Cellular Biochemistry, 412(1-2), 269-280. Scopus44 WoS39 Europe PMC31 |
| 2015 | Saad, M. I., Abdelkhalek, T. M., Saleh, M. M., Kamel, M. A., Youssef, M., Tawfik, S. H., & Dominguez, H. (2015). Insights into the molecular mechanisms of diabetes-induced endothelial dysfunction: focus on oxidative stress and endothelial progenitor cells. Endocrine, 50(3), 537-567. Scopus53 WoS50 Europe PMC39 |
| 2015 | Saad, M. I., Kamel, M. A., Abdelkhalek, T. M., Saleh, M. M., & Tawfik, S. H. (2015). Recent patents and advances in regenerative medicine and stem cell therapies for diabetes, cardiovascular and neurodegenerative diseases. Recent Patents on Regenerative Medicine, 5(1), 36-54. |
| 2015 | Saad, M. I., Kamel, M. A., & Hanafi, M. Y. (2015). Modulation of adipocytokines production and serum NEFA level by metformin, glimepiride, and sitagliptin in HFD/STZ diabetic rats. Biochemistry Research International, 2015, 7 pages. Scopus34 WoS28 Europe PMC28 |
| 2015 | Tawfik, S. H., Mahmoud, B. F., Saad, M. I., Shehata, M., Kamel, M. A., & Helmy, M. H. (2015). Similar and additive effects of ovariectomy and diabetes on insulin resistance and lipid metabolism. Biochemistry Research International, 2015, 8 pages. Scopus51 WoS50 Europe PMC39 |
| 2014 | I Saad, M., A Kamel, M., Y Hanafi, M., H Helmy, M., & R Shehata, R. (2014). Effect of Sitagliptin and Glimepiride on Glucose Homeostasis and cAMP Levels in Peripheral Tissues of HFD/STZ Diabetic Rats. American Journal of Biomedical Research, 2(3), 52-60. |
| Date | Role | Research Topic | Program | Degree Type | Student Load | Student Name |
|---|---|---|---|---|---|---|
| 2025 | Principal Supervisor | Investigating the ADAM family of proteases as potential therapeutic targets in small cell lung cancer | Master of Philosophy (Medical Science) | Master | Full Time | Mrs Heba Mohamed Abdelazim Khattab |
| 2025 | Principal Supervisor | Investigating the rhomboid family of pseudoproteases (iRhoms) as potential therapeutic targets in lung cancer | Master of Philosophy (Medical Science) | Master | Full Time | Ms Shermin Yu Tung Chan |
| 2025 | Principal Supervisor | Investigating the rhomboid family of pseudoproteases (iRhoms) as potential therapeutic targets in lung cancer | Master of Philosophy (Medical Science) | Master | Full Time | Ms Shermin Yu Tung Chan |
| 2024 | Co-Supervisor | Optimization of diagnosis and identification of therapeutic targets for advanced lung and pleural malignancy. | Master of Philosophy (Medical Science) | Master | Full Time | Miss Jelena Solujic |